{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:16:48Z","timestamp":1789179408625,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","thebonejournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.bone.2017.01.011","type":"journal-article","created":{"date-parts":[[2017,1,14]],"date-time":"2017-01-14T16:00:16Z","timestamp":1484409616000},"page":"121-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["A novel SLC12A1 gene mutation associated with hyperparathyroidism, hypercalcemia, nephrogenic diabetes insipidus, and nephrocalcinosis in four patients"],"prefix":"10.1016","volume":"97","author":[{"given":"Sariya","family":"Wongsaengsak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaina P.","family":"Vidmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananta","family":"Addala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine S.","family":"Kamil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Sequeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Fass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pisit","family":"Pitukcheewanont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2017.01.011_bb0005","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.V93516","article-title":"Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. 1962","author":"Bartter","year":"1998","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.bone.2017.01.011_bb0010","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/ndt\/gfn689","article-title":"Phenotype-genotype correlation in antenatal and neonatal variants of Bartter syndrome. [Internet]. 2008\/12\/20","volume":"24","author":"Brochard","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"issue":"10\u221211","key":"10.1016\/j.bone.2017.01.011_bb0015","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1007\/PL00013418","article-title":"Phenotypic variability in Bartter syndrome type I","volume":"14","author":"Bettinelli","year":"2000","journal-title":"Pediatr. Nephrol."},{"issue":"3","key":"10.1016\/j.bone.2017.01.011_bb0020","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s004670050280","article-title":"Bartter syndrome in Costa Rica: a description of 20 cases","volume":"11","author":"Madrigal","year":"1997","journal-title":"Pediatr. Nephrol."},{"issue":"3","key":"10.1016\/j.bone.2017.01.011_bb0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0002-9343(01)01086-5","article-title":"Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies","volume":"112","author":"Peters","year":"2002","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.bone.2017.01.011_bb0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000076752","article-title":"Bartter's and Gitelman's syndromes: from gene to clinic","volume":"96","author":"Naesens","year":"2004","journal-title":"Nephron Physiol."},{"issue":"5","key":"10.1016\/j.bone.2017.01.011_bb0035","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00041552-200309000-00008","article-title":"Bartter syndrome","volume":"12","author":"Hebert","year":"2003","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"10","key":"10.1016\/j.bone.2017.01.011_bb0040","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s12098-014-1379-6","article-title":"Genetic analysis in Bartter syndrome from India","volume":"81","author":"Sharma","year":"2014","journal-title":"Indian J. Pediatr."},{"issue":"1","key":"10.1016\/j.bone.2017.01.011_bb0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00424-013-1370-5","article-title":"Physiology and pathophysiology of SLC12A1\/2 transporters","volume":"466","author":"Markadieu","year":"2014","journal-title":"Pflugers Arch."},{"issue":"3","key":"10.1016\/j.bone.2017.01.011_bb0050","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1095-6433(01)00420-2","article-title":"Ion transport and ligand binding by the Na-K-Cl cotransporter, structure-function studies","volume":"130","author":"Isenring","year":"2001","journal-title":"Comp. Biochem. Physiol. A Mol. Integr. Physiol."},{"issue":"5","key":"10.1016\/j.bone.2017.01.011_bb0055","first-page":"229","article-title":"Neonatal bartter syndrome","volume":"69","author":"Wong","year":"2014","journal-title":"Med. J. Malays."},{"issue":"4","key":"10.1016\/j.bone.2017.01.011_bb0060","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s004670050131","article-title":"A case of neonatal Bartter's syndrome","volume":"10","author":"Wong","year":"1996","journal-title":"Pediatr. Nephrol."},{"issue":"8","key":"10.1016\/j.bone.2017.01.011_bb0065","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3345\/kjp.2010.53.8.809","article-title":"A case of Bartter syndrome type I with atypical presentations","volume":"53","author":"Lee","year":"2010","journal-title":"Korean J. Pediatr."},{"issue":"2","key":"10.1016\/j.bone.2017.01.011_bb0070","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00467-008-0999-3","article-title":"Atypical phenotype of type I Bartter syndrome accompanied by focal segmental glomerulosclerosis","volume":"24","author":"Yamazaki","year":"2009","journal-title":"Pediatr. Nephrol."},{"issue":"8","key":"10.1016\/j.bone.2017.01.011_bb0075","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1681\/ASN.2005101071","article-title":"Late-onset manifestation of antenatal Bartter syndrome as a result of residual function of the mutated renal Na+-K+-2Cl\u2212 co-transporter","volume":"17","author":"Pressler","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.bone.2017.01.011_bb0080","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/ndt\/gfn689","article-title":"Phenotype-genotype correlation in antenatal and neonatal variants of Bartter syndrome","volume":"24","author":"Brochard","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"issue":"7\u20138","key":"10.1016\/j.bone.2017.01.011_bb0085","first-page":"943","article-title":"Antenatal Bartter syndrome presenting as hyperparathyroidism with hypercalcemia and hypercalciuria: a case report and review","volume":"28","author":"Gross","year":"2015","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.bone.2017.01.011_bb0090","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1210\/jc.2016-1211","article-title":"Association of mutations in SLC12A1 encoding the NKCC2 cotransporter with neonatal primary hyperparathyroidism","volume":"101","author":"Li","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.bone.2017.01.011_bb0095","doi-asserted-by":"crossref","first-page":"F1143","DOI":"10.1152\/ajprenal.00396.2011","article-title":"Molecular regulation of NKCC2 in the thick ascending limb","volume":"301","author":"Ares","year":"2011","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"10","key":"10.1016\/j.bone.2017.01.011_bb0100","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s12098-014-1379-6","article-title":"Genetic analysis in Bartter syndrome from India","volume":"81","author":"Sharma","year":"2014","journal-title":"Indian J. Pediatr."},{"issue":"6","key":"10.1016\/j.bone.2017.01.011_bb0105","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1086\/301872","article-title":"Novel molecular variants of the Na-K-2Cl cotransporter gene are responsible for antenatal Bartter syndrome","volume":"62","author":"Vargas-Poussou","year":"1998","journal-title":"Am. J. Hum. Genet."},{"issue":"9","key":"10.1016\/j.bone.2017.01.011_bb0110","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1093\/ndt\/gfq119","article-title":"Long-term follow-up of patients with Bartter syndrome type I and II","volume":"25","author":"Puricelli","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"issue":"6","key":"10.1016\/j.bone.2017.01.011_bb0115","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1097\/01.ASN.0000064948.39199.A0","article-title":"Mutations in the human Na-K-2Cl cotransporter (NKCC2) identified in Bartter syndrome type I consistently result in nonfunctional transporters","volume":"14","author":"Starremans","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.bone.2017.01.011_bb0120","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1097\/01.ASN.0000064948.39199.A0","article-title":"Mutations in the human Na-K-2Cl cotransporter (NKCC2) identified in Bartter syndrome type I consistently result in nonfunctional transporters","volume":"14","author":"Starremans","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.bone.2017.01.011_bb0125","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3345\/kjp.2010.53.8.809","article-title":"A case of Bartter syndrome type I with atypical presentations","volume":"53","author":"Lee","year":"2010","journal-title":"Korean J. Pediatr."},{"issue":"3","key":"10.1016\/j.bone.2017.01.011_bb0130","doi-asserted-by":"crossref","first-page":"170","DOI":"10.6065\/apem.2015.20.3.170","article-title":"XYY syndrome: a 13-year-old boy with tall stature","volume":"20","author":"Jo","year":"2015","journal-title":"Ann. Pediatr. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bone.2017.01.011_bb0135","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jpeds.2013.05.037","article-title":"47, XYY syndrome: clinical phenotype and timing of ascertainment","volume":"163","author":"Bardsley","year":"2013","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.bone.2017.01.011_bb0140","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00467-008-0999-3","article-title":"Atypical phenotype of type I Bartter syndrome accompanied by focal segmental glomerulosclerosis","volume":"24","author":"Yamazaki","year":"2009","journal-title":"Pediatr. Nephrol."},{"issue":"4","key":"10.1016\/j.bone.2017.01.011_bb0145","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/qjmed\/93.4.207","article-title":"Bartter syndrome: an overview","volume":"93","author":"Amirlak","year":"2000","journal-title":"QJM"},{"issue":"4 Pt 1","key":"10.1016\/j.bone.2017.01.011_bb0150","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0022-3476(05)82480-1","article-title":"Calcium homeostasis and hypercalciuria in hyperprostaglandin E syndrome","volume":"120","author":"Leonhardt","year":"1992","journal-title":"J. Pediatr."},{"issue":"11","key":"10.1016\/j.bone.2017.01.011_bb0155","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.clinthera.2005.11.015","article-title":"Cinacalcet: an oral calcimimetic agent for the management of hyperparathyroidism","volume":"27","author":"Dong","year":"2005","journal-title":"Clin. Ther."},{"issue":"3","key":"10.1016\/j.bone.2017.01.011_bb0160","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/2042018813482344","article-title":"Experience with cinacalcet in primary hyperparathyroidism: results after 1year of treatment","volume":"4","author":"Luque-Fernandez","year":"2013","journal-title":"Ther. Adv. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bone.2017.01.011_bb0165","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/MJT.0b013e3181bdc3d0","article-title":"Cinacalcet for the treatment of primary hyperparathyroidism","volume":"18","author":"Dillon","year":"2011","journal-title":"Am. J. Ther."},{"issue":"2","key":"10.1016\/j.bone.2017.01.011_bb0170","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000350540","article-title":"Neonatal hypercalcemia due to a homozygous mutation in the calcium-sensing receptor: failure of cinacalcet","volume":"104","author":"Garc\u00eda Soblechero","year":"2013","journal-title":"Neonatology"},{"issue":"4","key":"10.1016\/j.bone.2017.01.011_bb0175","doi-asserted-by":"crossref","first-page":"E707","DOI":"10.1210\/jc.2010-1306","article-title":"Neonatal hyperparathyroidism with a heterozygous calcium-sensing receptor (CASR) R185Q mutation: clinical benefit from cinacalcet","volume":"96","author":"Reh","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.bone.2017.01.011_bb0180","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00467-016-3337-1","article-title":"Accentuated hyperparathyroidism in type II Bartter syndrome","volume":"31","author":"Landau","year":"2016","journal-title":"Pediatr. Nephrol."},{"issue":"11","key":"10.1016\/j.bone.2017.01.011_bb0185","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1007\/s00467-014-2846-z","article-title":"Phosphate homeostasis in Bartter syndrome: a case-control study","volume":"29","author":"Bettinelli","year":"2014","journal-title":"Pediatr. Nephrol."},{"issue":"7","key":"10.1016\/j.bone.2017.01.011_bb0190","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nrneph.2016.59","article-title":"Localization and function of the renal calcium-sensing receptor","volume":"12","author":"Riccardi","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"issue":"4","key":"10.1016\/j.bone.2017.01.011_bb0195","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejmg.2016.02.001","article-title":"Neonatal severe hyperparathyroidism caused by homozygous mutation in CASR: a rare cause of life-threatening hypercalcemia","volume":"59","author":"Murphy","year":"2016","journal-title":"Eur. J. Med. Genet."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632821730011X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632821730011X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T18:56:31Z","timestamp":1658429791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S875632821730011X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":39,"alternative-id":["S875632821730011X"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2017.01.011","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel SLC12A1 gene mutation associated with hyperparathyroidism, hypercalcemia, nephrogenic diabetes insipidus, and nephrocalcinosis in four patients","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2017.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}